Valuation check: ELUT's profit margin is -4920.04%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Elutia (ELUT) currently reports a profit margin of -4920.04% as of June 2026. That compares with -90.94% in the prior-year period — down 5310.3% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Elutia's profit margin history and peer comparisons.
Elutia's profit margin decreased from -90.94% to -4920.04% — a 5310.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Elutia's profit margin of -4920.04% is lower than the Healthcare sector average of 21.34%. That is roughly 23160.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Elutia's current -4920.04% should be judged against Healthcare norms (sector average: 21.34%) and against ELUT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -4920.04%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Elutia, and consider following ELUT for alerts when major investors trade the stock.